TPST
TPST
NASDAQ · Biotechnology

Tempest Therapeutics Inc

$0.40
+0.02 (+6.09%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +10,912.6% upside
Low Target $35.70
Average Target $43.72
High Target $58.20
Current Price $0.40
Current
$0.40
Target
$43.72
$35.70 $43.72 avg $58.20
Scenario Analysis
Bear Case
$35.70
8,892.4%
Low target
Base Case
$43.72
+10,912.6%
Avg target
Bull Case
$58.20
+14,559.9%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$10.33
-96.2% from high
52-Week Low
$0.37
+7.1% from low
Target vs 52W High
$43.72
+323.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%